Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
Front Oncol
; 13: 1259314, 2023.
Article
in En
| MEDLINE
| ID: mdl-38053658
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Front Oncol
Year:
2023
Type:
Article
Affiliation country:
Italy